These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5789542)

  • 21. [Antigenic characteristics of an influenza A2 virus isolated in Montreal during the outbreak of 1967-1968].
    Boudreault A; Podoski MO; Pavilanis V
    Can J Public Health; 1969 May; 60(5):203-8. PubMed ID: 4978411
    [No Abstract]   [Full Text] [Related]  

  • 22. Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.
    Stephenson I; Bugarini R; Nicholson KG; Podda A; Wood JM; Zambon MC; Katz JM
    J Infect Dis; 2005 Apr; 191(8):1210-5. PubMed ID: 15776364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the inactivation of the A2 Hong-Kong influenza virus with gamma rays].
    De Flora S; Badolati G; Bernardi G
    G Ig Med Prev; 1969; 10(4):403-10. PubMed ID: 5406290
    [No Abstract]   [Full Text] [Related]  

  • 24. [An influenza outbreak of type A and type B influenza viruses].
    Profeta ML; Pontello M; Zanchetta N
    Boll Ist Sieroter Milan; 1983 Mar; 62(1):47-55. PubMed ID: 6639772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antigenic drift of a strain of influenza equi virus isolated in France during the winter of 1978-1979].
    Plateau E; Crucière C; Gayot G
    Ann Rech Vet; 1983; 14(1):71-7. PubMed ID: 6614786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of Chincoteague ponies to antigenically dissimilar strains of human type A2 influenza virus.
    Kasel JA; Fulk RV; Harvey EW
    J Immunol; 1969 Aug; 103(2):369-71. PubMed ID: 5803793
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection.
    Ansaldi F; Canepa P; Parodi V; Bacilieri S; Orsi A; Compagnino F; Icardi G; Durando P
    Vaccine; 2009 May; 27(25-26):3345-8. PubMed ID: 19200846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia.
    Guo YJ; Krauss S; Senne DA; Mo IP; Lo KS; Xiong XP; Norwood M; Shortridge KF; Webster RG; Guan Y
    Virology; 2000 Feb; 267(2):279-88. PubMed ID: 10662623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of influenza C virus in Czechoslovakia and German Democratic Republic.
    Tůmová B; Scharfenorth H; Adamczyk G
    Acta Virol; 1983 Nov; 27(6):502-10. PubMed ID: 6140836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenic analysis of the hemagglutinating subunits of the animal influenza virus strains A-equine-2-Milford-2-63, A-equine-2-Miami-1-63 and A-Duck-England-62.
    Drescher J; Weidauer D
    J Immunol; 1969 Apr; 102(4):1050-7. PubMed ID: 5768184
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative analysis of influenza virus strains isolated in Poland during the epidemic season 1981-1982].
    Loza-Tulimowska M; Isaczenko WA; Lubowcewa OW; Iwanowa WT; Zakstelskaja LJ; Semkow RA
    Med Dosw Mikrobiol; 1984; 36(1):27-32. PubMed ID: 6738227
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathogenicity and antigenicity of a new influenza A (H5N1) virus isolated from duck meat.
    Lu X; Cho D; Hall H; Rowe T; Sung H; Kim W; Kang C; Mo I; Cox N; Klimov A; Katz J
    J Med Virol; 2003 Apr; 69(4):553-9. PubMed ID: 12601764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of antineuraminidase antibodies in protection against influenza].
    Aymard M; Gerentes L; Kessler N
    Bull Acad Natl Med; 1998; 182(8):1723-36; discussion 1736-7. PubMed ID: 10188318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and antigenic analysis of the influenza virus responsible for the 1992 Hong Kong equine influenza epizootic.
    Lai AC; Lin YP; Powell DG; Shortridge KF; Webster RG; Daly J; Chambers TM
    Virology; 1994 Nov; 204(2):673-9. PubMed ID: 7941336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is Hong Kong strain influenza a new virus?
    Nahum LH
    Conn Med; 1969 Aug; 33(8):509-10. PubMed ID: 5802861
    [No Abstract]   [Full Text] [Related]  

  • 37. Antigenic variation in influenza viruses in man and animals.
    Pereira HG
    Proc R Soc Med; 1969 Jan; 62(1):43-4. PubMed ID: 5763468
    [No Abstract]   [Full Text] [Related]  

  • 38. An overview of influenza haemagglutinin and neuraminidase.
    Skehel J
    Biologicals; 2009 Jun; 37(3):177-8. PubMed ID: 19272795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on Influenza virus A-Torino 1-1968].
    Giuliani G; Paggi GC; Novara O
    G Mal Infett Parassit; 1968 Sep; 20(9):812-5. PubMed ID: 5710691
    [No Abstract]   [Full Text] [Related]  

  • 40. Influenza: the Hong Kong virus.
    Lane WR
    Med J Aust; 1969 Jul; 2(1):58. PubMed ID: 5799015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.